Patent US4681759A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4681759A Expired / Lapsed US ⏱️ 0.0 years remaining

Rioprostil-PVP complex

Assignee: Ortho Pharmaceutical Corp
•
Filing: 1985-05-08
•
Granted: 1987-07-21
•
Expires: 2005-05-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A rioprostil/PVP complex is disclosed which is formed by lyophilization, evaporation or spray drying processes, and formed into improved solid dosage form for oral administration of cytoprotection and gastrointestinal lesions.

Inventors

  • 👤 Linda S. Porubcan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 22:33
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/557; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/58

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 23 words
A rioprostil: non-crosslinked polyvinylpyrrolidone complex of 1 mole fraction of rioprostil per 21/2 mole fraction of polyvinylpyrrolidone monomeric subunits in dry solid form.
Claim 2
Dependent Claim 23 words
A rioprostil: non-crosslinked polyvinylpyrrolidone complex of 1 mole fraction of rioprostil per 21/2 mole fraction of polyvinylpyrrolidone monomeric subunits in dry solid form.
Claim 3
Dependent Claim 8 words
The complex of claim 1 in powdered form.
Claim 4
Dependent Claim 36 words
A pharmaceutical composition for oral administration to mammals to induce cytoprotection or prevent gastrointestinal lesions or treat gastrointestinal lesions comprising, as the active ingredient, the rioprostil: polyvinylpyrrolidone complex of claim 2 and a pharmaceutically acceptable carrier.
Claim 5
Dependent Claim 12 words
The pharmaceutical composition of claim 3 in the form of a tablet.
Claim 6
Dependent Claim 12 words
The pharmaceutical composition of claim 3 in the form of a capsule.

References Cited (Backward Citations)

US3826823A Cited
US4301146A Cited
DE3304867A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-07-20 1991-01-19 1991-07-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-07-20 1995-01-19 1995-07-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-07-20 1999-01-19 1999-07-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag